Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

DOR BioPharma Receives EMEA Agreement On The Design Of Its Confirmatory Phase 3 Clinical Trial Of OrBec(R) In GI GVHD
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biopharmaceutical company, announced that it has received Protocol Assistance feedback from the European Medicines Agency (EMEA) on the design of its confirmatory, pivotal, Phase 3 clinical trial evaluating its lead product orBec(R) for the treatment of acute gastrointestinal Graft-versus-Host Disease (GI GVHD).

New Snapshots Show States Vary Widely In Providing Quality Health Care, USA
The Agency for Healthcare Research and Quality"s annual release of state-by-state quality data continues to give states mixed reviews for the quality of care they provide. As in previous years, AHRQ"s 2008 State Snapshots show that no state does well or poorly on all quality measures.
News of the day
Thousands Of Pennsylvania Graduates Need Health Insurance Options
Employers will hire 22 percent fewer college graduates in 2009 than they did last year, according to the National Association of Colleges and Employers. That means thousands of Pennsylvania college students graduating this spring may be without health insurance coverage due to unemployment or time elapsing before starting a new job.
Diagnostics

Schering-Plough Announces U.S. Filing Of Mometasone Furoate/Formoterol Fumarate Combination For The Maintenance Treatment Of Asthma

including Item 1A. "Risk Factors" in Schering-Plough"s first quarter 2009 10-Q, filed May 1, 2009 References 1. IMS Midas data, 2003-2008. 2. "Asthma Facts and Figures." Asthma and Allergy Foundation of America, 2005. 3. "What is asthma?" National Heart Lung and Blood Institute. National Institutes of Health, September 2008. Schering-Plough Corporation

Pages: 1 [2] 


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009